Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immix Biopharma Inc (IMMX)

Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immix Biopharma Inc 11400 WEST OLYMPIC BLVD SUITE 200 LOS ANGELES CA 90064 USA

www.immixbio.com Employees: 21 P: 310-651-8041

Sector:

Medical

Description:

Immix Biopharma Inc. is a biopharmaceutical company pioneering Tissue Specific Therapeutics (TM) targeting oncology and immuno-dysregulated diseases. Immix Biopharma Inc. is based in LOS ANGELES.

Key Statistics

Overview:

Market Capitalization, $K 388,160
Enterprise Value, $K 370,480
Shares Outstanding, K 52,955
Float, K 23,618
% Float 44.60%
Short Interest, K 2,990
Short Float 5.65%
Days to Cover 3.11
Short Volume Ratio 0.36
% of Insider Shareholders 55.40%
% of Institutional Shareholders 11.26%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -21,610 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,590 K
EBIT, $ -24,050 K
EBITDA, $ -23,930 K

Growth:

1-Year Return 310.10%
3-Year Return 220.09%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.24 on 11/07/25
Next Earnings Date 03/23/26
Earnings Per Share ttm -0.77
EPS Growth vs. Prev Qtr -9.09%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IMMX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -263.56%
Return-on-Assets % -119.99%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 29.70
Book Value/Share 0.25
Interest Coverage -0.90
60-Month Beta 0.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar